Dr. David A. Morrow, MD

Dr. Morrow practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Morrow's NPI, 1316928039, was assigned on November 9, 2005. Dr. Morrow graduated from Harvard Medical School in 1994. Dr. Morrow holds Massachusetts license 152630.

Dr. Morrow's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Morrow's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Morrow is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Morrow to 3 more hospitals, 1 hospice and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morrow practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Morrow's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Morrow is licensed in Massachusetts.

CMS data shows 1,427 Medicare services from Dr. Morrow across 5 procedure codes in 2024, for 1,054 Medicare patients. Medicare paid $36,961 for them.

CMS counts 1,054 Medicare patients who saw Dr. Morrow in 2024. The largest group is 65 to 74, with 399 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morrow's median patient age at 72, with 40% women.

In 2024, Dr. Morrow wrote 957 Medicare Part D claims for 131 patients. 79% of them were for generic drugs. CMS names the drug for 841 of them, across 21 drugs with 11 or more claims each, at $240,288 in total drug cost. In 2023, CMS named 736 claims across 17 drugs.

Dr. Morrow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Morrow as offering telehealth.

Dmand AI links 205 papers to Dr. Morrow, published from 2016 to 2025. 2024 was the busiest year, with 34. The most frequent topics are Shock, Cardiogenic, Heart Failure and Hospital Mortality. Dr. Morrow has published most often in Eur Heart J Acute Cardiovasc Care. Dr. Morrow's most frequent co-authors are David Douglas Berg, MD, Erin Ann Bohula, MD and Marc S. Sabatine, MD.

CMS Open Payments shows 139 general payments to Dr. Morrow from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Roche Diagnostics International Ltd paid the most, $53,028. It also lists 11 research payments totaling $1,335 from 2016 to 2024.

Dr. Morrow graduated from Harvard Medical School in 1994.